Andere Sprachen ANI Pharmaceuticals, Inc.

Aktien

A1W15D

US00182C1036

ANIP

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
65.36 ^USD	+0.63%		-0.18%	+18.53%

17.04.	Insider von Ani Pharmaceuticals verkaufte Aktien im Wert von $1.500.589, laut einer aktuellen SEC-Einreichung	MT
09.04.	ANI Pharmaceuticals, Inc. kündigt die Markteinführung von Baclofen Oral Suspension an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET	18.04.
Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing	17.04.
ANI Pharmaceuticals : Corporate Presentation - April 2024	17.04.
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension	09.04.
ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension	09.04.
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis	04.04.
Ani Pharmaceuticals Insider Sold Shares Worth $1,345,000, According to a Recent SEC Filing	03.04.
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium	03.04.
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP	27.03.
ANI Pharmaceuticals, Inc. Announces the Launch of Levofloxacin Oral Solution, USP	27.03.
ANI Pharmaceuticals : Corporate Presentation - March 2024	12.03.
Ani Pharmaceuticals Insider Sold Shares Worth $671,700, According to a Recent SEC Filing	12.03.
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing	08.03.
Ani Pharmaceuticals Insider Sold Shares Worth $456,400, According to a Recent SEC Filing	06.03.
Ani Pharmaceuticals Insider Sold Shares Worth $330,000, According to a Recent SEC Filing	06.03.
Sector Update: Health Care Stocks Decline Late Afternoon	29.02.
Sector Update: Health Care Stocks Retreat Thursday Afternoon	29.02.
ANI Pharmaceuticals Shares Rise After Q4 Adjusted Earnings, Net Revenue Beat Forecasts	29.02.
ANI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
ANI: Q4 Earnings Snapshot	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ANI Pharmaceuticals, Inc.

Aktien

A1W15D

US00182C1036

ANIP

Andere Sprachen

Filter